Clean Control Corporation’s Germ Control 24 ™ Featured on Nationally Televised “Geraldo At Large”
SDC-Based Disinfectant Available at Leading Home Improvement Retailer
WARNER ROBINS, GA, November 20, 2007—Clean Control Corporation, manufacturer of Germ Control 24™, a revolutionary disinfectant containing PURE Bioscience’s (OTCBB: PURE) patented silver dihydrogen citrate (SDC), announced today that Germ Control 24 was discussed during a live interview on the nationally televised program “Geraldo at Large.” Host Geraldo Rivera interviewed PURE Bioscience CEO, Michael Krall who presented Germ Control 24 as an example of the company’s SDC-based disinfectants. The superior broad-spectrum efficacy combined with reduced toxicity of SDC-based disinfectants make them ideal for the control and prevention of dangerous bacteria and viruses such as much discussed Methicillin Resistant Staphylococcus Aureus (MRSA), Avian influenza (SARS surrogate) and Norovirus (cruise ship illness).
The program’s medical expert, Dr. Bob Arnot, Disaster Medical Specialist, commented, “You know what I like about it is the EPA IV [rating]. There is so much stuff out there you want to clean your house with that [is] toxic to the environment – it’s certainly a plus in that category...If you are going to clean your countertops; if you are going to clean different surfaces in your house, I think it’s a good idea.”
Clean Control’s Germ Control 24 is a private label brand of PURE Bioscience’s SDC-based disinfectant and is available to consumers nationwide at a leading home improvement retailer and through Clean Control. Stephen Davison, President of Clean Control Corporation, stated, “Recognition of Germ Control 24 as a breakthrough disinfectant is quickly gaining momentum, especially with the continued media coverage of MRSA. We expect that Sunday’s prime-time exposure on the Fox News network will fuel the already-growing interest in Germ Control 24.
Michael L. Krall, President and CEO of PURE Bioscience, added, “The opportunity to speak to a national audience about the power of SDC is always a pleasure. We appreciate and value any forum to raise public awareness of SDC as a very real solution for preventable nationwide health concerns such as MRSA, norovirus, Bird Flu and SARS.”
The TV interview followed bold statements the previous week from former Secretary of Health and Human Services, Governor Tommy Thompson, who serves on the PURE Board of Directors, about the importance of prevention and the significance of PURE Bioscience’s SDC technology as a solution.
PURE Bioscience’s silver dihydrogen citrate (SDC)-based disinfectant is registered with the EPA under the trade name Axen30® and is effective against bacteria, viruses and fungi. Independent lab studies and resulting EPA-registered claims document that PURE’s disinfectant kills resistant strains of bacteria, including MRSA (Methicillin-resistant Staphylococcus aureus), CA-MRSA, PVL-MRSA and VRE (Vancomycin resistant Enterococcus faecium) in just two minutes. In addition, SDC-based disinfectants provide a 30 second kill and 24-hour residual protection against Staphylococcus aureus, Pseudomonas aeruginosa, Salmonella choleraesuis. Notable viral efficacy claims for PURE’s disinfectant include a three-minute kill against Human Corona virus (SARS surrogate) and Rotavirus and a ten-minute kill against Norovirus and Avian Influenza A (Bird Flu). Moreover, SDC-based disinfectants pose little if any health hazards because they are odorless, colorless, non-corrosive, non-flammable and are compatible with other disinfecting and cleaning chemicals.
About Clean Control Corporation
Founded in 1980, Clean Control Corporation currently manufactures many cleaning solutions, including OdoBan The Original Odor Eliminator since 1980. Clean Control Corporation is a premier manufacturer of high-quality cleaning products for household, institutional, and commercial use worldwide. For additional information visit the Company’s website: www.cleancontrol.com.
About PURE Bioscience
PURE Bioscience develops and markets technology-based bioscience products that provide solutions to numerous global health challenges, including Staph (MRSA). PURE's proprietary high efficacy/low toxicity bioscience technologies, including its SDC-based antimicrobials, represent innovative advances in diverse markets and lead today's global trend toward industry and consumer use of "green" products while providing competitive advantages in efficacy and safety. Patented SDC is an electrolytically generated source of stabilized ionic silver, which formulates well with other compounds. As a platform technology, SDC is distinguished from competitors in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it. PURE is headquartered in
This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project,” "expect" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, acceptance of the Company's current and future products and services in the marketplace, the ability of the Company to develop effective new products and receive regulatory approvals of such products, competitive factors, dependence upon third-party vendors, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.
# # #